home All News open_in_new Full Article

China vital to Insilico’s plan to build biotech’s AI ‘Einstein’ for drug discovery

Biotech firm Insilico Medicine, backed by the Hong Kong Investment Corporation (HKIC), is building a “digital Einstein” to revolutionise how scientists discover new medicines, and plans to continue expanding its research base in China to stay ahead of global rivals after its Hong Kong listing on Tuesday. “Biotechnology is a high-risk field like a ‘molecular casino’,” said founder Alex Zhavoronkov. “Even with artificial intelligence, you can lose 90 per cent of the time.” The 11-year-old company...


today 3 w. ago attach_file Events

attach_file Politics
attach_file Events
attach_file Politics
attach_file Technology
attach_file Events
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Science
attach_file Politics
attach_file Politics
attach_file Politics


ID: 114688591
Add Watch Country

arrow_drop_down